Zanubrutinib
Spécifications
1691249-45-2Numéro CAS
184-710-7Numéro CE
(7S)-2-(4-phenoxyphenyl)-7-(1-prop-2-enoylpiperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamideNom IUPAC
C27H29N5O3Formule chimique
471.5 g/molMasse molaire
Zanubrutinib; 1691249-45-2; Brukinsa; BGB-3111; AG9MHG098Z; (7S)-2-(4-PHENOXYPHENYL)-7-[1-(PROP-2-ENOYL)PIPERIDIN-4-YL]-4H,5H,6H,7H-PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE; (S)-7-(1-Acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide; (7S)-2-(4-Phenoxyphenyl)-7-(1-(prop-2-enoyl)piperidin-4-yl)-4,5,6,7-tetrahydropyrazolo(1,5-a)pyrimidine-3-carboxamide; (7S)-2-(4-phenoxyphenyl)-7-(1-prop-2-enoylpiperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide; DTXSID701026208; (7S)-4,5,6,7-Tetrahydro-7-[1-(1-oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide; Pyrazolo(1,5-a)pyrimidine-3-carboxamide, 4,5,6,7-tetrahydro-7-(1-(1-oxo-2-propen-1-yl)-4-piperidinyl)-2-(4-phenoxyphenyl)-, (7S)-; Pyrazolo[1,5-a]pyrimidine-3-carboxamide, 4,5,6,7-tetrahydro-7-[1-(1-oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)-, (7S)-; zanubrutinibum; (7S)-2-(4-phenoxyphenyl)-7-(1-(prop-2-enoyl)piperidin-4-yl)-4H,5H,6H,7H-pyrazolo(1,5-a)pyrimidine-3-carboxamide; (7S)-2-(4-phenoxyphenyl)-7-(1-prop-2-enoylpiperidin-4-yl)-4,5,6,7-tetrahydropyrazolo(1,5-a)pyrimidine-3-carboxamide; (7S)-2-(4-Phenoxyphenyl)-7-[1-(prop-2-enoyl)piperidin-4-yl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide; (7S)-4,5,6,7-Tetrahydro-7-(1-(1-oxo-2-propen-1-yl)-4-piperidinyl)-2-(4-phenoxyphenyl)pyrazolo(1,5-a)pyrimidine-3-carboxamide; (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo(1,5-a)pyrimidine-3-carboxamide; BTK-InhB; RefChem:57294; DTXCID701510461; Zanubrutinib [INN]; Zanubrutinib [USAN]; Zanubrutinib (BGB-3111); BGB3111; C27H29N5O3; Brukinsa (TN); MFCD31567461; 1691249-45-2 (S-isomer); Zanubrutinib (Standard); ZANUBRUTINIB [MI]; Zanubrutinib [USAN:INN]; UNII-AG9MHG098Z; BGB-3111(Zanubrutinib)?; ZANUBRUTINIB [WHO-DD]; GTPL9861; orb1299685; orb3141425; Zanubrutinib (JAN/USAN/INN); CHEMBL3936761; SCHEMBL17842597; BDBM250082; BDBM784667; GLXC-21435; ZANUBRUTINIB [ORANGE BOOK]; compound 27b [US9447106]; EX-A3602; HY-101474AR; EBC-27179; NSC823807; AKOS032944849; AT18252; DB15035; HY-101474A; NSC-823807; US20250340560, Compound 27b; US9447106, 27b (peak 2); BP-44065; BS-15529; BZ168474; DA-68805; PD077832; CS-0021869; T7584; D11422; EN300-22831096; F981177; (7S)-2-(4-phenoxyphenyl)-7-(1-prop-2-enoyl-4-piperidyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide; 1651179-04-2; 7-(1-acryloyl-4-piperidinyl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo(1,5-a)pyrimidine-3-carboxamide; Brukinsa; (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamideSynonymes
Aucune entreprise, produit ou article trouvé pour cette substance pour le moment.